← Browse by Condition
Medical Condition

recurrent pancreatic adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07226856 Phase 2
Recruiting

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Enrollment
43 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →